Genotarget

GenoTarget is a biotechnology company specializing in advanced gene editing technologies, particularly CRISPR/Cas9. The company provides a comprehensive suite of services including the development of genetically modified animal models, engineered cell lines, and viral vector construction to support drug discovery and basic research. By leveraging its proprietary platforms, GenoTarget assists pharmaceutical and academic partners in validating therapeutic targets and accelerating the development of gene and cell therapies. Their expertise spans across various therapeutic areas, with a strong focus on oncology and rare genetic disorders. The company operates primarily as a contract research organization (CRO), offering high-precision genomic tools to global clients to facilitate the transition from target discovery to clinical application.